Cited by 42Thyroid Disorders and TreatmentsPharmacogenetics and Drug MetabolismDrug-Induced Hepatotoxicity and Protection

The DOI matches its Crossref record.

Interaction Between Rifampin and Levothyroxine

NOLAN, STEVEN R., SELF, TIMOTHY H., NORWOOD, JOHN M.·1999·Southern Medical Journal

Abstract

Rifampin is a potent inducer of hepatic enzymes and is well documented to cause many clinically significant drug interactions. Studies in normal volunteers have shown its ability to decrease circulating levels of thyroid hormone, while having no effect on thyroid-stimulating hormone (TSH). Reports of rifampin's effects on patients on hormone replacement in the clinical setting are of interest since we believe only one such case has been described. We report the case of a man, stable on levothyroxine, who exhibited significantly elevated TSH levels during therapy with rifampin. Thyroid-stimulating hormone levels returned to baseline 9 days after discontinuance of rifampin.

Overview

Integrity signals

Registry

Crossref · 10.1097/00007611-199905000-00018

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cited by

Sorted by citations

See all 42

Metadata

Authors
NOLAN, S. R., SELF, T. H., & NORWOOD, J. M.
Affiliations
University of Tennessee Health Science Center (US)
Venue
Southern Medical Journal
Published
1999-05
Volume
92
Issue
5
Pages
529-531
ISSN
0038-4348 (ISSN-L)
OpenAlex
W1507088428
Cited by
42
References
0
Citations by year
2025: 1 · 2024: 1 · 2023: 2 · 2022: 4 · 2017: 2 · 2015: 3 · 2013: 2 · 2012: 1
FWCI
3.01
Type
journal article
Language
en
Open access
closed
Locations
  • Southern Medical Journal (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
rifampicin, levothyroxine, drug interactions, thyroid-stimulating hormone, thyroid hormones, enzyme induction, hormone replacement therapy
MeSH terms
Drug Interactions, Enzyme Induction, Humans, Hypothyroidism, Liver, Male, Middle Aged, Rifampin, Surgical Wound Infection, Thyrotropin, Thyroxine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review